TRexBio
PrivateLast Round
Series B
Extension
Jan 27, 2026
Total Funding Raised
$219M
Momentum Score
25 /100
Company Overview
TRexBio is a biotechnology company that develops therapeutics aimed at treating immune-mediated diseases by mapping human tissue behavior to disease processes to identify novel therapeutic targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRexBio Comps
Public and private peers based on sector, stage, and business model.
TRexBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 27, 2026 | ||||
| Series B | Nov 13, 2024 | ||||
| Series A Extension | Mar 8, 2022 | ||||
| Series A | Jun 22, 2021 |
Key People
Founding team and executive leadership
TRexBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B Extension |
| Agent Capital | Series B |
| Balyasny Asset Management L.P. | Series B Extension |
| SV Health Investors | Series B, Series A, Series A Extension, Series B Extension, Seed |
| Avego BioScience Capital | Series B, Series B Extension |
| Alexandria Venture Investments | Series B, Series A, Series A Extension, Series B Extension |
| Pfizer Ventures | Series B, Series A, Series A Extension, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2026
$50M Series B Extension round completed.
TRexBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TRexBio's valuation, stock price, and market status.
